Clinical Trial Update: Clinical Trial to Evaluate the Efficacy and Safety of Pirtobrutinib With Rituximab in Patients With Mantle Cell Lymphoma [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating the efficacy and safety of pirtobrutinib in combination with rituximab for Mantle Cell Lymphoma; currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Mantle Cell Lymphoma

Drugs mentioned

• Pirtobrutinib (LOXO-305) (pirtobrutinib)
• Rituximab (rituximab)

Snippet

Sponsor: Grupo Español de Linfomas y Transplante Autólogo de Médula Ósea | Conditions: Mantle Cell Lymphoma (MCL) | Phase 2 | Status: RECRUITING